U.S. Trial With AstraZeneca's Coronavirus Vaccine Expected to Resume Soon
The FDA's review of a serious illness that occurred among a clinical trial volunteer is finally wrapping up.
The FDA's review of a serious illness that occurred among a clinical trial volunteer is finally wrapping up.